bioRxiv Science⌕ Search

Biology subjects

Arnese, R.

Publications and source records attributed to Arnese, R..

5 recordsLinked to original sources

ESMRank reveals a transferable axis of protein mutational constraint from overlapping variant effect assays

Proteome-wide interpretation of missense variation is constrained not only by predictive model performance but also by the absence of principled methods to reconcile heterogeneous multiplexed assays of variant effect (MAVEs) into a unified representation of mutational constraint. We show that redundancy among partially overlapping deep mutational scanning experiments encodes a reproducible ordinal signal that can be recovered despite differences in assay scale and readout. We introduce variant soundness, an overlap-aware framework that aligns within-assay rankings and aggregates them across experiments to derive an assay-agnostic, within-protein measure of mutational tolerance. Applying this approach to about 1,100 MAVEdb score sets spanning >2M variants reveals a coherent constraint landscape enriched for structural stability determinants, including residue burial, packing perturbation magnitude, and domain architecture. By aligning learning objectives with this intrinsic ordering, we develop ESMRank, a sequence-based learning-to-rank predictor integrating protein language model representations with physicochemical descriptors. Under strict protein-level partitioning, ESMRank outperforms widely used stability and fitness predictors across the Human Domainome, ProteinGym stability assays, and VariBench folding kinetics. Without clinical supervision, the reconstructed constraint axis is enriched for ClinVar pathogenic variants and stratifies genes by mechanistic disease classes. In CFTR, predicted constraint tracks folding efficiency, channel activity, and pharmacological rescue. These findings establish experimental overlap as a scalable resource for extracting transferable mutational ordering and for building mechanistically interpretable, proteome-wide variant effect predictors.

bioinformatics↗

Model-independent reorganization of translation in TDP-43 Amyotrophic Lateral Sclerosis

The RNA-binding protein TDP-43 is a major contributor and a pathological hallmark of Amyotrophic Lateral Sclerosis (ALS), yet how TDP-43 dysregulation mechanistically alters protein synthesis across neuronal compartments and disease models remains unclear. Here, we dissected TDP-43-driven translational alterations in both in vitro and in vivo TDP-43 models of ALS. Through ribosome and polysome profiling, computational, and biochemical analyses, we observed robust TDP-43-associated translational remodelling at cellular and subcellular resolution. Our findings reveal a conserved mechanism across models, characterized by enhanced ribosome recruitment on polysomes, elongation impairment, axonal downregulation and instability of TDP-43 target mRNAs and redistribution toward non-target transcripts. Notably, TDP-43 dysregulation alters ribosome dynamics and selectively impairs translation of TDP-43 target mRNAs, whilst favouring the translation of other transcripts. This process reflects a compensatory but maladaptive response to TDP-43-induced mRNA destabilization. Together, these data demonstrate that alterations in TDP-43 disrupts neuronal proteostasis through ribosome reorganization and loss of mRNA homeostasis, providing a unifying mechanistic framework for translational imbalance in ALS and revealing early molecular events that may underlie motor neuron vulnerability.

molecular biology↗

A fluorescent folding reporter uncovers myosin misfolding as a driver of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a fatal genetic disorder causing the thickening of ventricular walls in the heart muscle. While certain mutations in cardiac myosin deregulate ATPase activity, the pathology mechanism of most HCM mutations is not known. Here, by designing a fluorescent reporter to monitor myosin folding in cells, we uncovered a distinct class of HCM mutations that cause graded defects in myosin maturation. Using C. elegans as a disease model, we found that folding deficient HCM variants cause myofilament disruption, impaired motility, and reduced lifespan. Dietary restrictions resulted in a near-complete recovery from these detrimental defects by activating autophagy pathways through insulin/TOR signaling. In conclusion, our study identifies myosin misfolding as an important driver of HCM, revealing therapeutic opportunities to counteract muscle protein disorders.

cell biology↗

Single cell lineage tracing reveals subclonal dynamics of anti-EGFR therapy resistance in triple negative breast cancer.

Epidermal growth factor receptor (EGFR)-targeted therapies have demonstrated variable and unpredictable clinical responses in triple negative breast cancer (TNBC). To elucidate the underlying mechanisms of this variability, we employ cellular barcoding and single-cell transcriptomics to reconstruct the subclonal dynamics of EGFR-amplified TNBC cells in response to afatinib, a tyrosine kinase inhibitor (TKI) that irreversibly inhibits EGFR. Integrated lineage tracing analysis revealed a rare pre-existing subpopulation of cells with distinct biological signature, including elevated expression levels of IGFBP2 (Insulin-Like Growth Factor Binding Protein 2). We show that IGFBP2 overexpression is sufficient to render TNBC cells tolerant to afatinib treatment by activating the compensatory IGF1-R signalling pathway. Finally, based on reconstructed mechanisms of resistance, we employ deep learning techniques to predict the afatinib sensitivity of TNBC cells. Our strategy proved effective in reconstructing the complex signalling network driving EGFR-targeted therapy resistance, offering new insights for the development of individualized treatment strategies in TNBC.

cancer biology↗

UNC-45 assisted myosin folding depends on a conserved FX3HY motif implicated in Freeman Sheldon Syndrome

Myosin motors are critical for diverse motility functions ranging from cytokinesis and endocytosis to muscle contraction. The UNC-45 chaperone controls myosin function mediating the folding, assembly, and degradation of the muscle protein. Here, we analyze the molecular mechanism of UNC-45 as a hub in myosin quality control. We show that UNC-45 forms discrete complexes with folded and unfolded myosin, forwarding them to downstream chaperones and E3 ligases. Structural analysis of a minimal chaperone:substrate complex reveals that UNC-45 binds to a conserved FX3HY motif in the myosin motor domain. Disrupting the observed interface by mutagenesis prevents myosin maturation leading to protein aggregation in vivo. We also show that a mutation in the FX3HY motif linked to the Freeman Sheldon Syndrome impairs UNC-45 assisted folding, reducing the level of functional myosin. These findings demonstrate that a faulty myosin quality control is a critical yet unexplored cause of human myopathies.

biochemistry↗